Spurred, in part, by concerns over contaminated heparin products produced with Chinese ingredients, the US Food and Drug Administration (FDA) is taking steps to expand its presence in the People's Republic of China.
The agency has received approval from the US State Department to establish 8 full-time permanent FDA positions at US diplomatic posts in China and is awaiting approval of the move from Chinese officials. The agency also plans to hire 5 Chinese nationals to work with the new FDA staff members, who will be based in Beijing, Shanghai, and Guangzhou. The changes are expected to take place over the next 18 months.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.